A comparison of primary laser vs delayed laser after bevacizumab for type 1 retinopathy of prematurity (ROP)

Juliann E. Lajoie,Richard Pacheco,Kate Tauber,Gil Binenbaum,Gerard P. Barry

Journal of American Association for Pediatric Ophthalmology and Strabismus（2021）

引用 0|浏览0

暂无评分

摘要

While type 1 ROP may initially be treated with bevacizumab, subsequent laser may be required. We sought to compare the characteristics of laser photocoagulation performed as primary treatment vs “delayed” laser performed after primary bevacizumab treatment for type 1 ROP.

查看译文

关键词

retinopathy,primary laser,bevacizumab,prematurity

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要